Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Nov 8, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Supernus Pharmaceuticals, Inc.
|
0
|
$23.06 | -$417,750.00 |
—
| 8.2K | +4 |
Nov 7
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
$24.04 | -$357,599.08 |
—
| 13.31K |
Nov 7
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
$22.91 | -$3,443,750.00 |
—
| 926.17K | +1 |
Nov 7
| ||||||
Supernus Pharmaceuticals, Inc.
| -3.89K |
$21.40 | -$320,448.38 | -22.59% | 13.31K |
Sep 13
| |||||||
Supernus Pharmaceuticals, Inc.
| 10.96K |
$34.90 | -$350,570.50 | +1.20% | 926.17K | +1 |
Sep 3
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Aug 27
| ||||||
Supernus Pharmaceuticals, Inc.
| 678 |
$29.57 | -$16,914.04 | +7.53% | 9.68K | +1 |
Aug 20
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Aug 1
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
$30.31 | -$145,054.91 |
—
| 8.57K | +1 |
Mar 21
|
Scheduled
| |||||
Supernus Pharmaceuticals, Inc.
|
0
|
$30.31 | -$4,004.00 |
—
| 8.57K | +1 |
Mar 20
|
Scheduled
| |||||
Supernus Pharmaceuticals, Inc.
|
0
|
$30.31 | -$123,763.64 |
—
| 8.57K | +1 |
Mar 19
|
Scheduled
| |||||
Supernus Pharmaceuticals, Inc.
|
0
|
$25.68 | -$1,005,765.50 |
—
| 8.57K | +1 |
Mar 13
|
Scheduled
| |||||
Supernus Pharmaceuticals, Inc.
|
0
|
$22.99 | -$77,718.84 |
—
| 8.57K | +1 |
Mar 12
|
Scheduled
| |||||
Supernus Pharmaceuticals, Inc.
| 530 |
$27.94 | -$12,852.40 | +7.31% | 7.78K | +4 |
Feb 28
| ||||||
Supernus Pharmaceuticals, Inc.
| 18.21K |
$27.94 | -$469,056.72 | +2.03% | 915.22K | +1 |
Feb 28
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
$19.67 | -$105,400.00 |
—
| 8.57K | +1 |
Feb 26
|
Scheduled
| |||||
Supernus Pharmaceuticals, Inc.
| 3.89K |
—
|
—
| +3.32% | 120.97K |
Feb 23
| |||||||
Supernus Pharmaceuticals, Inc.
| 3.89K |
—
|
—
| +29.19% | 17.2K |
Feb 23
| |||||||
Supernus Pharmaceuticals, Inc.
| 3.89K |
—
|
—
| +29.19% | 17.2K |
Feb 23
| |||||||
Supernus Pharmaceuticals, Inc.
| 3.89K |
—
|
—
| +11.69% | 37.12K |
Feb 23
| |||||||
Supernus Pharmaceuticals, Inc.
| 3.89K |
—
|
—
| +4.62% | 87.94K |
Feb 23
| |||||||
Supernus Pharmaceuticals, Inc.
| 938 |
$29.06 | -$27,229.22 | +14.86% | 7.25K | +4 |
Feb 23
| ||||||
Supernus Pharmaceuticals, Inc.
| 612 |
$29.06 | -$18,540.28 | +7.69% | 8.57K | +1 |
Feb 23
| ||||||
Supernus Pharmaceuticals, Inc.
| 1.19K |
$29.06 | -$38,184.84 | +19.75% | 7.19K |
Feb 23
| |||||||
Supernus Pharmaceuticals, Inc.
| 683 |
$29.06 | -$16,477.02 | +17.26% | 4.64K | +1 |
Feb 23
| ||||||
Supernus Pharmaceuticals, Inc.
| 765 |
$29.06 | -$14,094.10 | +0.89% | 86.93K | +1 |
Feb 23
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
| 447 |
$27.94 | -$8,465.82 | +12.73% | 3.96K | +1 |
Feb 22
| ||||||
Supernus Pharmaceuticals, Inc.
| 378 |
$27.94 | -$10,393.68 | +4.99% | 7.96K | +1 |
Feb 22
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 22
| ||||||
Supernus Pharmaceuticals, Inc.
| 415 |
$27.94 | -$9,359.90 | +7.04% | 6.31K | +4 |
Feb 22
| ||||||
Supernus Pharmaceuticals, Inc.
| 500 |
—
|
—
| +9.08% | 6K |
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
| 504 |
$27.94 | -$6,873.24 | +0.59% | 86.17K | +1 |
Feb 22
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
| 1.92M | +1 |
Feb 12
| ||||||
Supernus Pharmaceuticals, Inc.
|
0
|
$18.58 | -$149,360.00 |
—
| 85.66K | +1 |
Jan 10
|
Scheduled
| |||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.